IP Library Granted Patent US 9,713,659
Granted Patent B2
US 9,713,659 · App. 15/185,165 · Granted Jul 25, 2017

Chlorhexidine gluconate compositions, resin systems and articles

Inventors: Vinod P. Menon (Woodbury, MN); Joseph D. Rule (Woodbury, MN); Richard B. Ross (Cottage Grove, MN); Deena M. Conrad-Vlasak (Stillwater, MN); Katie F. Wlaschin (St. Paul, MN)
Assignee: 3M Innovative Properties Company
A61L31/16A61L15/44A61L15/46A61L15/58A61L31/14A61L2300/206A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,713,659
App. No.
15/185,165
Granted
Jul 25, 2017
Kind
B2
Abstract

Compositions containing chlorhexidine gluconate solubilized in hydrophobic vehicles are described. Resin systems containing such chlorhexidine gluconate compositions, including adhesives and articles incorporating such resin systems, including medical articles such as drapes are also described.

Claims (32)

1. A composition comprising chlorhexidine gluconate solubilized in a hydrophobic vehicle having a hydrophilic-lipophilic balance of no greater than 10 as determined using the HLB Method,

wherein the hydrophobic vehicle comprises two proximate hydrogen-bonding groups,

wherein at least one of the hydrogen-bonding groups is a hydrogen donor,

wherein the composition comprises no greater than 0.1 parts by weight hydrophilic vehicle per 1 part by weight chlorhexidine gluconate, and

wherein the hydrophobic vehicle is a monoacylglycerol.

2. The composition of claim 1 , wherein an alkyl group of the monoacylglycerol is a C8 to C18 alkyl group.

3. The composition of claim 1 , wherein the monoacylglycerol is selected from the group consisting of glycerol monocaprylate, glycerol monolaurate, glycerol monoisostearate, glycerol monooleate, and combinations thereof.

4. The composition according to claim 1 , wherein the composition comprises no greater than 0.1 parts by weight water per 1 part by weight chlorhexidine gluconate.

5. The composition according to claim 1 , further comprising a resin system comprising a polymer.

6. The composition of claim 5 , wherein the resin system comprises a hydrophobic phase, wherein the hydrophobic vehicle plasticizes the hydrophobic phase.

7. The composition of claim 5 , wherein the polymer comprises an acrylate polymer.

8. The composition of claim 5 , wherein the polymer comprises a block copolymer polymer.

9. The composition according to claim 6 , wherein the resin system is a pressure sensitive adhesive.

10. An article comprising a substrate and the composition according to claim 1 bonded to at least a portion of a surface of the substrate.

11. The article according to claim 10 , wherein the article is a medical article.

12. The composition of claim 1 , wherein the monoacylglycerol is a 1-monoacylglyceride.

13. A composition comprising chlorhexidine gluconate solubilized in a hydrophobic vehicle having a hydrophilic-lipophilic balance of no greater than 10 as determined using the HLB Method,

wherein the hydrophobic vehicle comprises two proximate hydrogen-bonding groups,

wherein at least one of the hydrogen-bonding groups is a hydrogen donor,

wherein the composition comprises no greater than 0.1 parts by weight hydrophilic vehicle per 1 part by weight chlorhexidine gluconate, and

wherein the hydrophobic vehicle is a vicinal diol.

14. The composition according to claim 13 , wherein the vicinal diol is a 1,2-diol.

15. The composition according to claim 14 , wherein the vicinal diol is selected from the group consisting of 1,2-pentanediol, 1,2-hexanediol, 1,2-octane diol, 1,2-decane diol, 1,2,6-trihydroxy-hexane, and combinations thereof.

16. The composition according to claim 14 , wherein the vicinal diol is selected from the group consisting of diethyl-D-tartrate, diethyl-L-tartrate, dibutyl-L-tartrate, decaglyceryl tristearate, 1,3-dihydroxyacetone dimer, 2,3-butanediol, ethylhexyl glycerin, and combinations thereof.

17. An article comprising a substrate and the composition according to claim 13 bonded to at least a portion of a surface of the substrate.

18. The article according to claim 17 , wherein the article is a medical article.

19. A composition comprising chlorhexidine gluconate solubilized in a hydrophobic vehicle having a hydrophilic-lipophilic balance of no greater than 10 as determined using the HLB Method,

wherein the hydrophobic vehicle comprises two proximate hydrogen-bonding groups,

wherein at least one of the hydrogen-bonding groups is a hydrogen donor,

wherein the composition comprises no greater than 0.1 parts by weight hydrophilic vehicle per 1 part by weight chlorhexidine gluconate, and

wherein the hydrophobic vehicle is selected from the group consisting of 1,3-diols, 1,4-diols, and combinations thereof.

20. The composition according to claim 19 , wherein the 1,3-diol is selected from the group consisting of: 1,3-cyclohexanediol, 3-methyl-1,3-butanediol, 1,3-butanediol, 1,3-propanediol, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066445/0328 →
Continuity (3)
Continuation 14424186
Provisional Application 61694088 · Aug 28, 2012
Related Publication 20160296678A1 · Oct 13, 2016